Abstract
The aim of this study was to characterize a Bartonella strain (BA-1) isolated from a blood culture of an Italian, human immunodeficiency virus-positive patient with bacillary angiomatosis. We analyzed the isolate using molecular biology methods such as whole-cell fatty acid analysis, PCR-restriction fragment length polymorphism analysis, type-specific 16S rRNA PCRs, sequence analysis of the 16S rRNA, pulsed-field gel electrophoresis, and arbitrarily primed PCR. The BA-1 isolate turned out to be a Bartonella quintana strain, similar but not identical to B. quintana Oklahoma, which was used as a control strain.
Among the 14 species now included in the genus Bartonella, at least 7 are human pathogens. Bartonella henselae, the most common cause of cat scratch disease, and B. quintana, the trench fever bacillus, are related species that can also cause a common spectrum of clinical diseases such as bacillary angiomatosis (BA), peliosis hepatis, relapsing bacteremia with fever, chronic lymphadenopathy, and endocarditis. The isolation of Bartonella strains is not a straightforward task but is extremely important for both etiological diagnosis and genetic investigation of the isolates (21). We report molecular characterization of BA-1, a Bartonella strain isolated from a patient with BA.
In June 1997, a 37-year-old male who was a heroin user and had been infected with human immunodeficiency virus (HIV) since 1985 was admitted to the Arcispedale S. Maria Nuova (Reggio Emilia, Italy), presenting with high recurrent fever and multiple nodular papules over his whole integument. Histologic examination of a skin biopsy specimen showed features typical of BA. Warthin-Starry staining revealed a cluster of small bacilli. Echography showed that the liver was involved. Patient serum yielded a high diagnostic titer (1:512) when it was tested in an indirect immunofluorescence assay using B. henselae as an antigen. Three blood samples showed bacterial growth after 35 days of incubation in BACTEC bottles (BACTEC NR730; Becton Dickinson, Cockeysville, Md.). The organisms were subcultured in 5% CO2 at 37°C on brain heart infusion agar (BBL, Becton Dickinson) plates supplemented with 5% rabbit blood. After 4 to 7 days, 0.5- to 2-mm-diameter colonies were visible. The isolated organisms were small, gram-negative, oxidase- and catalase-negative, nonfermentative, nonmotile rods.
In this study, the following strains of three different species of Bartonella were used as positive controls: B. henselae Houston-1 (ATCC 49882, type I strain); B. henselae 269608 (type II strain) isolated at the University of California, Davis, from the blood of a 20-year-old pet cat from northern California; B. quintana Oklahoma, a blood culture strain isolated from an HIV-positive patient in Oklahoma; and B. clarridgeiae (ATCC 51734). B. henselae Pavia-1, isolated from a cat in Italy, was also included in the analysis (9).
Fatty acid methyl ester derivatives were prepared for gas chromatographic analysis by using the following four-phase procedure: saponification, methylation, extraction, and a base wash as described elsewhere (5). The fatty acid composition observed for the new isolate was characterized by a relatively simple profile: large amounts of C16:0 (hexadecanoic acid) (27.5%), C18:1ω7 (cis-11-octadecenoic acid) (39.5%), and C18:0 (octadecenoic acid) (31.8%) and minor amounts of C18:2ω6 (cis-9,12-octadecadienoic acid) (traces) and C18:1ω9 (cis-9-octadecanoic acid) (1.2%). The high similarity between the whole-cell fatty acid (CFA) composition of BA-1 and those of B. quintana, B. henselae, and B. clarridgeiae (data not shown) identified the isolate as a member of the genus Bartonella but did not allow identification of the species.
The primers BhCS.781p (5′-GGGGACCAGCTCATGGTGG-3′) and BhCS.1137n (5′-AATGCAAAAAGAACAGTAAACA-3′) were used to amplify a fragment of the Bartonella citrate synthase gene by PCR as previously described (15). The amplicons (379 bp) were subjected to restriction fragment length polymorphism (RFLP) analysis with TaqI restriction endonuclease (Fig. 1). We found identical profiles for B. henselae Houston-1, B. henselae 269608, and B. henselae Pavia-1 (bands of 171, 137, and 71 bp). Patterns were also identical in B. quintana Oklahoma and BA-1 (bands of 316 and 63 bp). The profile of the B. clarridgeiae reference strain was different from those of B. henselae and B. quintana.
FIG. 1.
PCR-RFLP analysis with TaqI restriction enzyme of the citrate synthase gene. Lanes: M, molecular marker VIII (Boehringer Mannheim, Mannheim, Germany); 1, B. henselae Houston-1 (ATCC49882, type I strain); 2, B. henselae 269608 (type II strain); 3, B. henselae Pavia-1; 4, BA-1; 5, B. quintana Oklahoma; 6, B. clarridgeiae (ATCC 51734). Values at the left are molecular sizes (in base pairs).
Amplification of the 16S rRNA gene with the universal primer 16SF [5′-AGAGTTTGATCCTGG(CT)TCAG-3′] and with either of the type-specific primers BH1 (5′-CCGATAAATCTTTCTCCCTAA-3′) and BH2 (5′-CCGATAAATCTTTCTCCAAAT-3′) was carried out as described elsewhere (1, 22). Two annealing temperatures were applied for PCR amplification: 56 and 58°C. As expected, the B. henselae Houston-1 and B. henselae Pavia-1 isolates yielded a PCR product in the type I PCR while B. henselae 269608 was positive in the type II PCR. Surprisingly, the BA-1 isolate and B. clarridgeiae yielded a PCR product when the primers specific for type I were used. Similarly to strain B. henselae Houston-1 and the reference strain of B. clarridgeiae, the new isolate was positive in the type I PCR when the DNA was amplified at 58°C. In contrast, B. quintana Oklahoma DNA was negative in both PCRs at both annealing temperatures (Fig. 2).
FIG. 2.
Type-specific 16S rRNA PCRs. PCR products were obtained at an annealing temperature of 58°C with primers BH1 (A) and BH2 (B). Lanes: M, molecular size marker VIII (Boehringer Mannheim); 1, B. henselae Houston-1 (ATCC 49882, type I strain); 2, B. henselae 269608 (type II strain); 3, B. henselae Pavia-1; 4, BA-1; 5, B. quintana Oklahoma; 6, B. clarridgeiae (ATCC 51734). The value at the left is a molecular size (in base pairs).
The 16S rRNA of the BA-1 isolate was amplified by using two universal eubacterial primers, 27f (5′-GAGAGTTTGATCCTGGCTCAG-3′) and 1495r (5′-CTACGGCTACCTTGTTACGA-3′) (24). The amplicon, a 1,455-bp product, was cloned in the pGEM-T easy vector (Promega, Madison, Wis.). Sequencing was performed with a commercial T7 sequencing kit (Pharmacia Biotech) with M13 forward and reverse primers, and results were analyzed on a Pharmacia Biotech ALFExpress automated DNA sequencer. The sequence obtained was compared to others by using the BLAST search tool (http://www.ncbi.n/m.nib.gov/BLAST/). The 16S rRNA gene sequence obtained (GenBank accession number AJ250247) revealed a 99% identity with the sequence described for B. quintana Fuller (GenBank accession number M11927), confirming the identification of BA-1 as B. quintana.
To further characterize the BA-1 isolate, pulsed-field gel electrophoresis (PFGE) and arbitrarily primed PCR (AP-PCR) were carried out. Genomic DNAs were prepared according to the procedure described by Maurin et al. (14) and were digested with SmaI (Fig. 3A). Among the five strains used as controls, B. quintana Oklahoma and B. clarridgeiae were easily distinguishable from one another and from the three B. henselae isolates by visual inspection. In contrast, very similar restriction patterns were obtained for B. henselae Houston-1, B. henselae 269608, and B. henselae Pavia-1. Very similar restriction patterns were also found for B. quintana Oklahoma and the BA-1 isolate. The restriction pattern of BA-1 showed 23 bands, 20 of which were common to the pattern found for B. quintana Oklahoma. With the Dice coefficient, the patterns of these two strains could be discriminated, having a cutoff of 94% similarity.
FIG. 3.
(A) PFGE analysis with SmaI and dendrogram of fingerprints determined by the Dice coefficient. The digestion products were separated at 190 V for 19 h in 1% agarose–0.25× Tris-borate-EDTA with a pulse time increasing from 3 to 10 s. (B) AP-PCR and dendogram of fingerprints determined by the Dice coefficient. Lanes: 1, B. henselae Houston-1 (ATCC 49882, type I strain); 2, B. henselae 269608 (type II strain); 3, B. henselae Pavia-1; 4, B. clarridgeiae (ATCC 51734); 5, BA-1; 6, B. quintana Oklahoma.
AP-PCR was performed with the core sequence of phage M13 (5′-GAGGGTGGCGGTTCT-3′) as described previously (11, 22). The fingerprints were analyzed with GelCompar software, Windows version 4.0 (Applied Maths, Kortrijk, Belgium) (Fig. 3B). The patterns produced were compared by using the Dice coefficient. For clustering, the unweighted pair group method with arithmetic means was used. Three groups were identified on the basis of AP-PCR fingerprints. Group I consisted solely of B. henselae strains. Group II contained B. quintana Oklahoma and the new isolate. Group III contained only the reference strain of B. clarridgeiae. The B. quintana Oklahoma and BA-1 isolates had a similarity level of 80% in the dendrogram and could thus be differentiated.
For further in-depth molecular studies, six biological methods were used to characterize the BA-1 isolate. All methods applied were found to be useful. The phenotypic characterization by CFA allowed for the identification of the isolate at the genus level, while the genotypic characterization by PCR-RFLP analysis of a fragment of the citrate synthase gene discriminated among B. henselae, B. quintana, and B. clarridgeiae and identified the BA-1 isolate as B. quintana. Amplification and sequencing of the complete 16S rRNA gene were also performed for the BA-1 isolate. The sequence obtained was almost identical to that of B. quintana Fuller.
Surprisingly, the type-specific PCRs with BH1 and BH2 were not as strictly species specific for B. henselae as expected. In fact, with the exception of B. quintana Oklahoma, all strains, including the type strain of B. clarridgeiae and the BA-1 isolate, yielded PCR products with these primers.
Compared with CFA and PCR-RFLP analysis, AP-PCR and PFGE showed a higher discriminatory power. As expected, both methods proved to be suitable for strain differentiation at the species level and sensitive in detecting minor differences among strains of the same Bartonella genus and species. Strains BA-1 and B. quintana Oklahoma produced similar but not identical PFGE and AP-PCR profiles. The genetic variation of B. quintana isolates was less pronounced than the variation of the three B. henselae isolates. The level of similarity among AP-PCR and PFGE fingerprints for B. quintana Oklahoma and BA-1 suggests that these two strains derive from different clones.
B. quintana is an emerging human pathogen that causes a wide spectrum of clinical diseases (urban trench fever, BA, peliosis hepatis, peliosis spleniitis, lymphadenopathy, and endocarditis) in both immunocompetent and immunocompromised hosts (16). Little is known about the geographical distribution of B. quintana in Europe. Although many B. quintana strains have been isolated in France (3, 4, 7, 8, 13, 14, 17, 18), the organism has rarely been recovered in other European countries (10, 23). In 1995, Drancourt et al. (7) reported the isolation of B. quintana from three homeless patients with endocarditis in France. Brouqui et al. (3) investigated the prevalence of Bartonella species in blood samples from all of the homeless people who availed themselves of the emergency department of the University Hospital, Marseille, France, between October 1993 and October 1994. For 10 out of 71 homeless patients (14%), blood cultures were positive for B. quintana, and in 21 of the patients (30%), high titers of antibodies against this organism were detected. No such epidemiological study has yet been carried out in Italy.
In conclusion, our study has shown that (i) B. quintana is an etiological agent of BA in Italy, (ii) the BA-1 isolate can be discerned from B. quintana Oklahoma, and (iii) contrarily to what we had expected, the type-specific primers BH1 and BH2 produced species-specific PCR products not only for B. henselae but for B. clarridgeiae and B. quintana BA-1 as well. Our results suggest that, in addition to B. henselae, B. quintana should be included as an antigen in the immunofluorescence test for the serological diagnosis of some Bartonella infections, even in those countries where trench fever and other B. quintana infections are not known to occur. Further investigations, however, are necessary (i) to determine the incidence of B. quintana infections, (ii) to establish whether more than one B. quintana clone exists in Italy, and (iii) to assess the degree of cross-reactivity between our isolate and the B. quintana Fuller strain. Urban trench fever has emerged among homeless persons in France (2), homeless, alcoholic, HIV-negative persons in Seattle, Wash. (12), and intravenous-drug abusers in Baltimore, Md. (6), and it has reemerged in Burundi after an absence of 12 years (19). B. quintana has been molecularly demonstrated to exist in body lice collected from homeless persons in Russia (20). All of this emphasizes the need for establishing regional surveillance laboratories for the detection and characterization of fastidious microbial pathogens as well as active surveillance programs. Outbreaks of louse-borne infections can occur in populations that live under squalid conditions (e.g., refugees or those left homeless as a consequence of war or natural disaster), where louse infestations are frequent. Even if the factors leading to outbreaks remain poorly understood, all methods for reducing louse infestation and avoiding crowding under poor hygienic conditions have been advocated as strategies for the prevention of B. quintana infection.
Acknowledgments
We thank M. Carla Liberto for the B. quintana Oklahoma strain.
REFERENCES
- 1.Bergmans A M C, Schellekens J F P, van Embden J D A, Schouls L M. Predominance of two Bartonella henselae variants among cat-scratch disease patients in The Netherlands. J Clin Microbiol. 1996;34:254–260. doi: 10.1128/jcm.34.2.254-260.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Brouqui P, Houpikian P, Tissot-Dupont H, Toubiana P, Obadia Y, Lafay V, Raoult D. Survey of the seroprevalence of Bartonella quintana in homeless people. Clin Infect Dis. 1996;23:756–759. doi: 10.1093/clinids/23.4.756. [DOI] [PubMed] [Google Scholar]
- 3.Brouqui P, La Scola B, Roux V, Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med. 1999;340:184–189. doi: 10.1056/NEJM199901213400303. [DOI] [PubMed] [Google Scholar]
- 4.Bruneel F, D'Estanque J, Fournier P E, Arlet G, Thuong M, Wolff M, Bedos J P, Lariven S, Regnier B. Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis. 1998;30:424–425. doi: 10.1080/00365549850160783. [DOI] [PubMed] [Google Scholar]
- 5.Cacciapuoti B, Ciceroni L, Attard Barbini D. Fatty acid profiles, a chemotaxonomic key for the classification of strains of the family Leptospiraceae. Int J Syst Bacteriol. 1991;41:295–300. [Google Scholar]
- 6.Comer J A, Flynn C, Regnery R L, Vlahov D, Childs J E. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med. 1996;156:2491–2495. [PubMed] [Google Scholar]
- 7.Drancourt M, Mainardi J L, Brouqui P, Vandenesch F, Carta A, Lehnert F, Etienne J, Goldstein F, Acar J, Raoult D. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med. 1995;332:419–423. doi: 10.1056/NEJM199502163320702. [DOI] [PubMed] [Google Scholar]
- 8.Drancourt M, Moal V, Brunet P, Dussol B, Berland Y, Raoult D. Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient. J Clin Microbiol. 1996;34:1158–1160. doi: 10.1128/jcm.34.5.1158-1160.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fabbi M, Chomel B B, Guicciardi L, Kasten R W, Marone P, Magnino S, Bragoni R, Carretto E, Taschini S. Isolamento di Bartonella henselae biotipo 1 e biotipo 2 da gatti in un paziente con CSD complicata da granulomatosi epato-splenica. Microbiol Med. 1999;14:111–112. [Google Scholar]
- 10.Goldenberger D, Schimdheini T, Altwegg M. Detection of Bartonella henselae and Bartonella quintana by a simple and rapid procedure using broad-range PCR amplification and direct single-strand sequencing of part of the 16S rRNA gene. Clin Microbiol Infect. 1997;3:240–245. doi: 10.1111/j.1469-0691.1997.tb00604.x. [DOI] [PubMed] [Google Scholar]
- 11.Gräser Y, Klare I, Halle E, Gantenberg R, Buchholz P, Jacobi H D, Presber W, Schönian G. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J Clin Microbiol. 1993;31:2417–2420. doi: 10.1128/jcm.31.9.2417-2420.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Jackson L A, Spach D H, Kippen D A, Sugg N K, Regnery R L, Sayers M H, Stamm W E. Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis. 1996;173:1023–1026. doi: 10.1093/infdis/173.4.1023. [DOI] [PubMed] [Google Scholar]
- 13.La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998) J Clin Microbiol. 1999;37:1899–1905. doi: 10.1128/jcm.37.6.1899-1905.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Maurin M, Roux V, Stein A, Ferrier F, Viraben R, Raoult D. Isolation and characterization by immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blot, restriction fragment length polymorphism-PCR, 16S rRNA gene sequencing, and pulsed-field gel electrophoresis of Rochalimaea quintana from a patient with bacillary angiomatosis. J Clin Microbiol. 1994;32:1166–1171. doi: 10.1128/jcm.32.5.1166-1171.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Norman A F, Regnery R, Jameson P, Greene C, Krause D C. Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene. J Clin Microbiol. 1995;33:1797–1803. doi: 10.1128/jcm.33.7.1797-1803.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ohl M E, Spach D H. Bartonella quintana and urban trench fever. Clin Infect Dis. 2000;31:131–135. doi: 10.1086/313890. [DOI] [PubMed] [Google Scholar]
- 17.Raoult D, Drancourt M, Carta A, Gastaut J A. Bartonella (Rochalimae) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat. Lancet. 1994;343:977. doi: 10.1016/s0140-6736(94)90102-3. [DOI] [PubMed] [Google Scholar]
- 18.Raoult D, Fournier P E, Drancourt M, Marrie T J, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclerq P, Sefton A M. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med. 1996;125:646–652. doi: 10.7326/0003-4819-125-8-199610150-00004. [DOI] [PubMed] [Google Scholar]
- 19.Raoult D, Ndihokubwayo J B, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, Birtles R J. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353–358. doi: 10.1016/s0140-6736(97)12433-3. [DOI] [PubMed] [Google Scholar]
- 20.Rydkina E B, Roux V, Gagua E M, Predtechenski A B, Tarasevich I V, Raoult D. Bartonella quintana in body lice collected from homeless persons in Russia. Emerg Infect Dis. 1999;5:176–178. doi: 10.3201/eid0501.990126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sander A. Microbiological diagnosis of Bartonella species and Afipia felis. In: Schmidt A, editor. Bartonella and Afipia species emphasizing Bartonella henselae. Vol. 1. Basel, Switzerland: Karger; 1998. pp. 98–112. [Google Scholar]
- 22.Sander A, Ruess M, Bereswill S, Schuppler M, Steinbrueckner B. Comparison of different DNA fingerprinting techniques for molecular typing of Bartonella henselae isolates. J Clin Microbiol. 1998;36:2973–2981. doi: 10.1128/jcm.36.10.2973-2981.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schmidt H U, Kaliebe T, Poppinger J, Buhler C, Sander A. Isolation of Bartonella quintana from an HIV-positive patient with bacillary angiomatosis. Eur J Clin Microbiol Infect Dis. 1996;15:736–741. doi: 10.1007/BF01691961. [DOI] [PubMed] [Google Scholar]
- 24.Tabacchioni S, Visca P, Chiarini L, Bevivino A, Di Serio C, Fancelli S, Fani R. Molecular characterization of clinical and environmental isolates of Burkholderia cepacia. Res Microbiol. 1995;146:531–542. doi: 10.1016/0923-2508(96)80559-6. [DOI] [PubMed] [Google Scholar]



